SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+1.02%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$224M
AUM Growth
+$224M
(-19%)
Cap. Flow
-$55.1M
Cap. Flow
% of AUM
-24.62%
Top 10 Holdings %
Top 10 Hldgs %
42.57%
Holding
53
New
5
Increased
12
Reduced
16
Closed
14
Top Buys
| 1 |
Merck
MRK
|
$8.16M |
| 2 |
Cencora
COR
|
$5.86M |
| 3 |
Biogen
BIIB
|
$4.63M |
| 4 |
Agilent Technologies
A
|
$4.54M |
| 5 |
Bruker
BRKR
|
$2.55M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$28.5M |
| 2 |
Charles River Laboratories
CRL
|
$6.77M |
| 3 |
Inspire Medical Systems
INSP
|
$5.91M |
| 4 |
Abbott
ABT
|
$5.68M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$5.02M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $13.6M | 4.88% | 15,000 -1,000 | -6% | -$905K |
|
2
Novo Nordisk
NVO
$251B
| $12.8M | 4.61% | 90,000 -2,500 | -3% | -$357K |
|
3
McKesson
MCK
$85.4B
| $10.5M | 3.78% | 18,000 +3,500 | +24% | +$2.04M |
|
4
Tenet Healthcare
THC
$16.3B
| $9.31M | 3.34% | 70,000 -5,000 | -7% | -$665K |
|
5
Boston Scientific
BSX
$156B
| $8.86M | 3.18% | 115,000 -20,000 | -15% | -$1.54M |
|
6
Stryker
SYK
$150B
| $8.51M | 3.06% | 25,000 | – | – |
|
|
7
Merck
MRK
$210B
| $8.16M | 2.93% | +65,874 | New | +$8.16M |
|
8
HCA Healthcare
HCA
$94.5B
| $8.03M | 2.88% | 25,000 +7,500 | +43% | +$2.41M |
|
9
Intuitive Surgical
ISRG
$170B
| $7.79M | 2.8% | 17,500 -2,500 | -13% | -$1.11M |
|
10
Thermo Fisher Scientific
TMO
$186B
| $7.74M | 2.78% | 14,000 -1,500 | -10% | -$830K |
|
11
Danaher
DHR
$147B
| $7.5M | 2.69% | 30,000 | – | – |
|
12
Universal Health Services
UHS
$11.6B
| $7.4M | 2.66% | 40,000 | – | – |
|
13
Vertex Pharmaceuticals
VRTX
$100B
| $7.03M | 2.53% | 15,000 +4,000 | +36% | +$1.87M |
|
|
14
Biogen
BIIB
$19.4B
| $6.96M | 2.5% | 30,000 +19,966 | +199% | +$4.63M |
|
15
Surgery Partners
SGRY
$2.91B
| $5.95M | 2.14% | 250,000 +60,000 | +32% | +$1.43M |
|
16
Cardinal Health
CAH
$35.5B
| $5.9M | 2.12% | 60,000 +15,000 | +33% | +$1.47M |
|
|
17
Cencora
COR
$56.5B
| $5.86M | 2.1% | +26,000 | New | +$5.86M |
|
18
Becton Dickinson
BDX
$55.3B
| $5.84M | 2.1% | 25,000 +10,000 | +67% | +$2.34M |
|
19
ResMed
RMD
$40.2B
| $5.74M | 2.06% | 30,000 -5,361 | -15% | -$1.03M |
|
20
Edwards Lifesciences
EW
$47.8B
| $5.54M | 1.99% | 60,000 -10,000 | -14% | -$924K |
|
21
Acadia Healthcare
ACHC
$2.12B
| $5.4M | 1.94% | 80,003 +10,003 | +14% | +$676K |
|
22
Avantor
AVTR
$9.18B
| $5.3M | 1.9% | 250,000 +36,053 | +17% | +$764K |
|
23
Select Medical
SEM
$1.61B
| $5.08M | 1.83% | 145,000 -55,000 | -28% | -$1.93M |
|
24
Insulet
PODD
$23.9B
| $5.05M | 1.81% | 25,000 -5,000 | -17% | -$1.01M |
|
25
Encompass Health
EHC
$12.3B
| $4.72M | 1.69% | 55,000 -5,000 | -8% | -$429K |
|